COVID‐19 and autoimmune rheumatic disease: behavioural changes adopted by patients amid the pandemic
Internal Medicine Journal · 2024
DOI: 10.1111/imj.16406 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Dzifa Dey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Therapeutics, University of Ghana Medical School, Accra, Ghana. Hauptthemen laut MEDLINE: COVID-19, Rheumatic Diseases, Autoimmune Diseases. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
Amid concerns about severe COVID‐19 in patients with autoimmune rheumatic disease (AIRD) during the outbreak, it is crucial to explore behavioural changes, whether healthy or unhealthy, arising from this patient population in response to the changing healthcare environment.
Aim
To investigate COVID‐19‐driven behavioural changes in patients with AIRD.
Methods
This observational study invited patients who attended the rheumatology clinic of the Korle Bu Teaching Hospital from 1 August 2020 to 1 July 2021, to respond to a survey questionnaire distributed on the patient's WhatsApp platform. Variables observed were changes in patient behaviour and decision‐making related to medication, healthcare service utilisation and clinical advice.
Results
Results for 233 patients were analysed in the study, the majority (89.7%) of whom were women. The most significant behavioural changes were a reduction in hydroxychloroquine (HCQ) dosage, adoption of telemedicine for clinical consultation and keen adherence to protective/preventive health measures. Patients also expressed anxiety regarding the risk of contracting COVID‐19 (52.5%), infecting their families (66.5%) and losing income (50.2%) due to the pandemic. Women and students were more likely to engage in self‐isolation/shielding behaviour. Employed participants practised social distancing more, reduced HCQ dosage and had more fear of losing income. Having mixed connective tissue disease is associated with being anxious about the risk of COVID‐19 infection.
Conclusion
The COVID‐19 pandemic has resulted in behaviour changes among patients with AIRD. Despite the perceived risk, most of these patients continue to adhere to their prescribed medication regimens, especially maintaining the dosage of traditional immunosuppressive agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Therapeutics, University of Ghana Medical School, Accra, Ghana.
- Department of Medicine and Therapeutics, Korle-Bu Teaching Hospital, Accra, Ghana.
ORCID-Profile: Dzifa Dey
Zitieren
APA
Dey, D., Katso, B., Issaka, S., & Adjei, P. (2024). COVID‐19 and autoimmune rheumatic disease: behavioural changes adopted by patients amid the pandemic. Internal Medicine Journal. https://doi.org/10.1111/imj.16406
Vancouver
Dey D, Katso B, Issaka S, Adjei P. COVID‐19 and autoimmune rheumatic disease: behavioural changes adopted by patients amid the pandemic. Internal Medicine Journal. 2024. doi:10.1111/imj.16406
BibTeX
@article{Dey2024,
author = {Dey, Dzifa and Katso, Bright and Issaka, Saudatu and Adjei, Patrick},
title = {COVID‐19 and autoimmune rheumatic disease: behavioural changes adopted by patients amid the pandemic},
journal = {Internal Medicine Journal},
year = {2024},
doi = {10.1111/imj.16406}
}
EUVIMED